MR-guided radiation therapy: transformative technology and its role in the central nervous system.

This review article describes advancement of magnetic resonance imaging technologies in radiation therapy planning, guidance, and adaptation of brain tumors. The potential for MR-guided radiation therapy to improve outcomes and the challenges in its adoption are discussed.

[1]  T. Mikkelsen,et al.  Predicting survival in glioblastomas using diffusion tensor imaging metrics , 2010, Journal of magnetic resonance imaging : JMRI.

[2]  P. Sundgren,et al.  Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions. , 2009, AJR. American journal of roentgenology.

[3]  T. Kazda,et al.  Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: Single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imaging , 2016, NeuroImage: Clinical.

[4]  K. Hess,et al.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. , 2009, The Lancet. Oncology.

[5]  Adam Johansson,et al.  CT substitute derived from MRI sequences with ultrashort echo time. , 2011, Medical physics.

[6]  M. Ruschin,et al.  Dosimetric Feasibility of the Hybrid Magnetic Resonance Imaging (MRI)-Linear Accelerator System for Brain Metastases: The Impact of the Magnetic Field , 2016 .

[7]  M. Essig,et al.  MR Imaging of Neoplastic Central Nervous System Lesions: Review and Recommendations for Current Practice , 2012, American Journal of Neuroradiology.

[8]  J. Lagendijk,et al.  Virtual couch shift (VCS): accounting for patient translation and rotation by online IMRT re-optimization , 2013, Physics in medicine and biology.

[9]  Thomas Filleron,et al.  Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme. , 2014, International journal of radiation oncology, biology, physics.

[10]  B. Erickson,et al.  Comprehensive MRI simulation methodology using a dedicated MRI scanner in radiation oncology for external beam radiation treatment planning. , 2014, Medical physics.

[11]  T. Hirai,et al.  Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. , 2007, Radiology.

[12]  Jong-Hee Chang,et al.  The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival , 2015, American Journal of Neuroradiology.

[13]  L Verhey,et al.  Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. , 2001, AJNR. American journal of neuroradiology.

[14]  A. Omuro,et al.  Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence , 2015, American Journal of Neuroradiology.

[15]  N. Lundbom,et al.  Spectroscopic imaging of radiation-induced effects in the white matter of glioma patients. , 2000, Magnetic resonance imaging.

[16]  D. Kong,et al.  Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status , 2011, American Journal of Neuroradiology.

[17]  Christopher H. Chapman,et al.  Radiation therapy effects on white matter fiber tracts of the limbic circuit. , 2012, Medical physics.

[18]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[19]  W. J. Lorenz,et al.  Correction of spatial distortion in magnetic resonance angiography for radiosurgical treatment planning of cerebral arteriovenous malformations. , 1992, Magnetic resonance imaging.

[20]  F. Yamasaki,et al.  Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging. , 2010, European journal of radiology.

[21]  P. LaViolette,et al.  Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma , 2016, American Journal of Neuroradiology.

[22]  Marco van Vulpen,et al.  Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review). , 2002, Oncology reports.

[23]  J. Lagendijk,et al.  The development of the MRI linac system for online MRI‐guided radiotherapy: a clinical update , 2016, Journal of internal medicine.

[24]  Yue Cao,et al.  Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Tianyu Zhao,et al.  Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications. , 2016, International journal of radiation oncology, biology, physics.

[26]  T. Kaminaga,et al.  Radiation-Induced Brain Metabolic Changes in the Acute and Early Delayed Phase Detected With Quantitative Proton Magnetic Resonance Spectroscopy , 2005, Journal of computer assisted tomography.

[27]  X. Li,et al.  Technical Note: Dose effects of 1.5 T transverse magnetic field on tissue interfaces in MRI-guided radiotherapy. , 2016, Medical physics.

[28]  P. Sundgren.  MR Spectroscopy in Radiation Injury , 2009, American Journal of Neuroradiology.

[29]  J. S. Laughlin,et al.  Choice of optimum megavoltage for accelerators for photon beam treatment. , 1986, International journal of radiation oncology, biology, physics.

[30]  Amirmohamad Keyvanloo Shahrestanaky.  Skin Dose in Longitudinal and Transverse Linac-MRIs using Monte-Carlo and realistic 3D MRI field models , 2013 .

[31]  Jeffrey A. Fessler,et al.  Regularized fieldmap estimation in MRI , 2006, 3rd IEEE International Symposium on Biomedical Imaging: Nano to Macro, 2006..

[32]  Timothy D Johnson,et al.  The parametric response map is an imaging biomarker for early cancer treatment outcome , 2009, Nature Medicine.

[33]  Susan M. Chang,et al.  Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging. , 2013, Neuro-oncology.

[34]  B G Fallone,et al.  Radio frequency shielding for a linac-MRI system. , 2010, Physics in medicine and biology.

[35]  M. Barton,et al.  The Potential for an Enhanced Role for MRI in Radiation-therapy Treatment Planning , 2013, Technology in cancer research & treatment.

[36]  B W Raaymakers,et al.  Fast online Monte Carlo-based IMRT planning for the MRI linear accelerator , 2012, Physics in medicine and biology.

[37]  Mary Feng,et al.  Assessing the Dosimetric Accuracy of Magnetic Resonance-Generated Synthetic CT Images for Focal Brain VMAT Radiation Therapy. , 2015, International journal of radiation oncology, biology, physics.

[38]  Yue Cao,et al.  Phantom-based characterization of distortion on a magnetic resonance imaging simulator for radiation oncology , 2016, Physics in medicine and biology.

[39]  Ying Lu,et al.  Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas , 2004, NMR in biomedicine.

[40]  David Gutman,et al.  Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. , 2013, Radiology.

[41]  J Balter,et al.  Patient-induced susceptibility effect on geometric distortion of clinical brain MRI for radiation treatment planning on a 3T scanner , 2013, Physics in medicine and biology.

[42]  J. Carl,et al.  Differences in supratentorial white matter diffusion after radiotherapy – new biomarker of normal brain tissue damage? , 2013, Acta oncologica.

[43]  C. Meyer,et al.  Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  B G Fallone,et al.  Effect of longitudinal magnetic fields on a simulated in-line 6 MV linac. , 2010, Medical physics.

[45]  Dieta Brandsma,et al.  Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. , 2008, The Lancet. Oncology.

[46]  B. Fallone,et al.  First MR images obtained during megavoltage photon irradiation from a prototype integrated linac-MR system. , 2009, Medical physics.

[47]  T. Cloughesy,et al.  Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy. , 2013, Neuro-oncology.

[48]  M. Berger,et al.  Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. , 2002, Journal of neurosurgery.

[49]  Hany Soliman,et al.  Chemical exchange saturation transfer for predicting response to stereotactic radiosurgery in human brain metastasis , 2017, Magnetic resonance in medicine.

[50]  Charis Kontaxis,et al.  A new methodology for inter- and intrafraction plan adaptation for the MR-linac , 2015, Physics in medicine and biology.

[51]  Sang Joon Kim,et al.  Pseudoprogression in Patients with Glioblastoma: Assessment by Using Volume-weighted Voxel-based Multiparametric Clustering of MR Imaging Data in an Independent Test Set. , 2015, Radiology.

[52]  P. Sundgren,et al.  MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury. , 2011, Academic radiology.

[53]  Susan M. Chang,et al.  Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. , 2001, Magnetic resonance imaging.

[54]  Douglas C. Miller,et al.  Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. , 2008, Radiology.

[55]  B Gino Fallone,et al.  A two-step scheme for distortion rectification of magnetic resonance images. , 2009, Medical physics.

[56]  Toshinori Hirai,et al.  Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.

[57]  V. Nagesh,et al.  Metabolic alterations: A biomarker for radiation‐induced normal brain injury—an MR spectroscopy study , 2009, Journal of magnetic resonance imaging : JMRI.

[58]  A. Dale,et al.  Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM , 2013, Front. Oncol..

[59]  Minsong Cao,et al.  Accuracy of UTE-MRI-based patient setup for brain cancer radiation therapy. , 2016, Medical physics.

[60]  Jan J W Lagendijk,et al.  The magnetic resonance imaging-linac system. , 2014, Seminars in radiation oncology.

[61]  Hauke Bartsch,et al.  Distortion inherent to magnetic resonance imaging can lead to geometric miss in radiosurgery planning. , 2016, Practical radiation oncology.

[62]  Vincent Magnotta,et al.  3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy. , 2014, International journal of radiation oncology, biology, physics.

[63]  Eun Ja Lee,et al.  Intracranial Metastases: Spectrum of Mr Imaging Findings , 2012, Acta radiologica.

[64]  H. Buchtel,et al.  Diffusion tensor imaging predicts cognitive function change following partial brain radiotherapy for low-grade and benign tumors. , 2016, Radiotherapy and Oncology.

[65]  Leland S. Hu,et al.  Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival , 2012, Neuro-oncology.

[66]  Yue Cao,et al.  A Radiation-Induced Hippocampal Vascular Injury Surrogate Marker Predicts Late Neurocognitive Dysfunction. , 2015, International journal of radiation oncology, biology, physics.

[67]  M. Pinho,et al.  Assessment of irradiated brain metastases using dynamic contrast-enhanced magnetic resonance imaging , 2014, Neuroradiology.

[68]  L Verhey,et al.  A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. , 2000, Neurosurgery.

[69]  Mary Feng,et al.  Investigation of a method for generating synthetic CT models from MRI scans of the head and neck for radiation therapy , 2013, Physics in medicine and biology.

[70]  J G M Kok,et al.  Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of concept , 2009, Physics in medicine and biology.

[71]  T. Hirai,et al.  Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up Study , 2008, American Journal of Neuroradiology.

[72]  E. Melhem,et al.  Radiation Injury to the Normal Brain Measured by 3D‐Echo‐Planar Spectroscopic Imaging and Diffusion Tensor Imaging: Initial Experience , 2015, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[73]  Yue Cao,et al.  Effect of the Maximum Dose on White Matter Fiber Bundles Using Longitudinal Diffusion Tensor Imaging. , 2016, International journal of radiation oncology, biology, physics.

[74]  Carri Glide-Hurst,et al.  Image Guided Radiation Therapy Using Synthetic Computed Tomography Images in Brain Cancer. , 2016, International journal of radiation oncology, biology, physics.

[75]  J Balter,et al.  Estimation of geometrically undistorted B(0) inhomogeneity maps. , 2014, Physics in medicine and biology.

[76]  A. Škoch,et al.  Potential of MR spectroscopy for assessment of glioma grading , 2013, Clinical Neurology and Neurosurgery.

[77]  Yue Cao,et al.  Physiological imaging-defined, response-driven subvolumes of a tumor. , 2013, International journal of radiation oncology, biology, physics.

[78]  Yue Cao,et al.  Investigation of the diffusion abnormality index as a new imaging biomarker for early assessment of brain tumor response to radiation therapy. , 2014, Neuro-oncology.

[79]  Yue Cao,et al.  Clinical investigation survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT , 2006 .

[80]  Jan J W Lagendijk,et al.  MRI/linac integration. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[81]  A. Sahgal,et al.  Backscatter dose effects for high atomic number materials being irradiated in the presence of a magnetic field: A Monte Carlo study for the MRI linac. , 2016, Medical physics.

[82]  David A Jaffray,et al.  Emergent technologies for 3-dimensional image-guided radiation delivery. , 2005, Seminars in radiation oncology.

[83]  M Takahashi,et al.  Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. , 2000, AJNR. American journal of neuroradiology.

[84]  W. Mason,et al.  Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma , 2014, American Journal of Neuroradiology.

[85]  W P Dillon,et al.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. , 2001, AJNR. American journal of neuroradiology.

[86]  P. Wen,et al.  A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients. , 2009, Cancer research.

[87]  Stephan E Maier,et al.  Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. , 2004, Neoplasia.

[88]  Timothy D Johnson,et al.  Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  Sami Hissoiny,et al.  Evaluation of a commercial MRI Linac based Monte Carlo dose calculation algorithm with GEANT4. , 2016, Medical physics.

[90]  L D Lunsford,et al.  Treatment planning for gamma knife radiosurgery with multiple isocenters. , 1990, International journal of radiation oncology, biology, physics.

[91]  Sasa Mutic,et al.  Quality of Intensity Modulated Radiation Therapy Treatment Plans Using a ⁶⁰Co Magnetic Resonance Image Guidance Radiation Therapy System. , 2015, International journal of radiation oncology, biology, physics.

[92]  Benoît Ozell,et al.  GPUMCD: A new GPU-oriented Monte Carlo dose calculation platform. , 2011, Medical physics.

[93]  Susan M. Chang,et al.  Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. , 1997, Journal of neurosurgery.

[94]  B. Fallone,et al.  The rotating biplanar linac-magnetic resonance imaging system. , 2014, Seminars in radiation oncology.

[95]  A N T J Kotte,et al.  Integrating a MRI scanner with a 6 MV radiotherapy accelerator: dose deposition in a transverse magnetic field. , 2004, Physics in medicine and biology.

[96]  E. Neuwelt,et al.  Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  B W Raaymakers,et al.  Integrating a MRI scanner with a 6 MV radiotherapy accelerator: impact of the surface orientation on the entrance and exit dose due to the transverse magnetic field , 2007, Physics in medicine and biology.

[98]  J. Michael Fitzpatrick,et al.  A technique for accurate magnetic resonance imaging in the presence of field inhomogeneities , 1992, IEEE Trans. Medical Imaging.

[99]  Tae Min Kim,et al.  Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging. , 2013, Radiology.

[100]  Olivier Salvado,et al.  An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy. , 2012, International journal of radiation oncology, biology, physics.

[101]  B W Raaymakers,et al.  Integrating a MRI scanner with a 6 MV radiotherapy accelerator: dose increase at tissue–air interfaces in a lateral magnetic field due to returning electrons , 2005, Physics in medicine and biology.

[102]  Sasa Mutic,et al.  The Design and Implementation of a Novel Compact Linear Accelerator-Based Magnetic Resonance Imaging-Guided Radiation Therapy (MR-IGRT) System. , 2016 .

[103]  T. Mikkelsen,et al.  Correlation between Magnetic Resonance Spectroscopy Imaging and Image-guided Biopsies: Semiquantitative and Qualitative Histopathological Analyses of Patients with Untreated Glioma , 2001, Neurosurgery.

[104]  C. Fuller,et al.  The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development , 2016, Front. Oncol..

[105]  Sasa Mutic,et al.  A Device for Realtime 3D Image-Guided IMRT , 2005 .

[106]  P. Jezzard,et al.  Correction for geometric distortion in echo planar images from B0 field variations , 1995, Magnetic resonance in medicine.

[107]  B G Fallone,et al.  Magnetic decoupling of the linac in a low field biplanar linac-MR system. , 2010, Medical physics.

[108]  Stephan E Maier,et al.  Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[109]  P J Keall,et al.  Electron contamination modeling and skin dose in 6 MV longitudinal field MRIgRT: Impact of the MRI and MRI fringe field. , 2012, Medical physics.

[110]  B. Nan,et al.  Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. , 2005, AJR. American journal of roentgenology.

[111]  Yue Cao,et al.  Physiologic and metabolic magnetic resonance imaging in gliomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[112]  J. Le Bas,et al.  Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. , 1998, International journal of radiation oncology, biology, physics.

[113]  H. Choy,et al.  Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. , 2013, International journal of radiation oncology, biology, physics.

[114]  D. Lim,et al.  Interfractional Variation of Radiation Target and Adaptive Radiotherapy for Totally Resected Glioblastoma , 2013, Journal of Korean medical science.

[115]  T. Chenevert,et al.  The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. , 2006, Cancer research.

[116]  P. Rana,et al.  Radiation‐induced early changes in the brain and behavior: Serial diffusion tensor imaging and behavioral evaluation after graded doses of radiation , 2012, Journal of neuroscience research.

[117]  Ying Lu,et al.  Survival analysis in patients with glioblastoma multiforme: Predictive value of choline‐to‐n‐acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume , 2004, Journal of magnetic resonance imaging : JMRI.

[118]  C. Meyer,et al.  Impact of perfusion map analysis on early survival prediction accuracy in glioma patients. , 2013, Translational oncology.

[119]  Yue Cao,et al.  Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]. , 2006, International journal of radiation oncology, biology, physics.

[120]  Sasa Mutic,et al.  The ViewRay system: magnetic resonance-guided and controlled radiotherapy. , 2014, Seminars in radiation oncology.

[121]  J J W Lagendijk,et al.  Dose optimization for the MRI-accelerator: IMRT in the presence of a magnetic field , 2007, Physics in medicine and biology.

[122]  Ying Lu,et al.  Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients , 2002, Journal of magnetic resonance imaging : JMRI.

[123]  Minsong Cao,et al.  Longitudinal diffusion MRI for treatment response assessment: Preliminary experience using an MRI-guided tri-cobalt 60 radiotherapy system. , 2016, Medical physics.

[124]  Sasa Mutic,et al.  Benchmark IMRT evaluation of a Co-60 MRI-guided radiation therapy system. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[125]  Bradford A Moffat,et al.  Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[126]  Toshinori Hirai,et al.  Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. , 2005, AJNR. American journal of neuroradiology.

[127]  B. Rosen,et al.  Susceptibility contrast imaging of cerebral blood volume: Human experience , 1991, Magnetic resonance in medicine.

[128]  D. Moses,et al.  Quantitative evaluation of diffusion-weighted imaging techniques for the purposes of radiotherapy planning in the prostate. , 2015, The British journal of radiology.

[129]  Douglas C Noll,et al.  An approach for computer-aided detection of brain metastases in post-Gd T1-W MRI. , 2012, Magnetic resonance imaging.

[130]  Jan J W Lagendijk,et al.  MR-guided breast radiotherapy: feasibility and magnetic-field impact on skin dose , 2013, Physics in medicine and biology.

[131]  Mitchel S Berger,et al.  3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. , 2004, International journal of radiation oncology, biology, physics.

[132]  Yue Cao,et al.  Regional Variation in Brain White Matter Diffusion Index Changes following Chemoradiotherapy: A Prospective Study Using Tract-Based Spatial Statistics , 2013, PloS one.

[133]  Yue Cao,et al.  Hypercellularity Components of Glioblastoma Identified by High b-Value Diffusion-Weighted Imaging. , 2015, International journal of radiation oncology, biology, physics.

[134]  J Debus,et al.  Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results. , 2003, Radiology.

[135]  Jeffrey A Fessler,et al.  A female pelvic bone shape model for air/bone separation in support of synthetic CT generation for radiation therapy , 2016, Physics in medicine and biology.

[136]  H. Buchtel,et al.  Diffusion tensor imaging of normal-appearing white matter as biomarker for radiation-induced late delayed cognitive decline. , 2012, International journal of radiation oncology, biology, physics.

[137]  M P Carol,et al.  MR-spectroscopy guided target delineation for high-grade gliomas. , 2001, International journal of radiation oncology, biology, physics.

[138]  M. Robbins,et al.  Molecular Pathways: Radiation-Induced Cognitive Impairment , 2013, Clinical Cancer Research.

[139]  B W Raaymakers,et al.  Fast dose calculation in magnetic fields with GPUMCD , 2011, Physics in medicine and biology.